{
    "2016-02-12": [
        "Dillon & Associates Inc. Raises Stake in Celgene Co. (CELG)",
        "PAAS Company Info Updated Friday, February 12, 2016 12:59:25 PM",
        "February 12 Biotech Update",
        "Mark Alles CELG new CEO said that this + GED301 will be sufficient to replace revlimid patent cliff in 2026"
    ]
}